Sacubitril/Valsartan Cannot Improve Cardiac Function Compared with Valsartan in Patients Suffering Nonvalvular Atrial Fibrillation without Systolic Heart Failure
This study investigates the effect of sacubitril/valsartan (Sac/Val) in patients diagnosed with nonvalvular atrial fibrillation (AF) without systolic heart failure (SHF).Nonvalvular AF patients without SHF admitted to the People's Hospital of Bortala Mongol Autonomous Prefecture from December 2020 to December 2021 were enrolled and randomly divided into Sac/Val treatment group (group T) and valsartan treatment group (group C, control). For subgroup analysis, patients were divided into subgroups with and without diastolic heart failure (DHF). After 1-month adaptive phase and subsequent 3-month treatment period, patients wer...
Source: International Heart Journal - November 29, 2023 Category: Cardiology Authors: Mingxin Zhu Jianfeng Guo Badeng Qiqike Xeri Nay Shan Dan Aidina Kuransi Gaokai Hu Zhangtong Han Dong Hou Ailifeilai Aili Bin Xia Ping Chen Bayin Bate Jiangjiao Xie Source Type: research
Adherence to Congestive Heart Failure Guidelines and Outcome in the Middle East
CONCLUSION: Despite of our full support to full CHFrEF guideline adherence, we recognize how hard this task to be achieved, nevertheless this study supports the theme that any guideline adherence is correlated with better morbidity and mortality rates over a long term follow up.PMID:38018202 | DOI:10.2174/011573403X256576231017110252 (Source: Current Cardiology Reviews)
Source: Current Cardiology Reviews - November 29, 2023 Category: Cardiology Authors: Raed Aqel Tareq Alzughayyar Jihad Zalloum Qais Salah Qutaiba Qafisheh Mahmoud Izraiq Source Type: research
Sacubitril/Valsartan Cannot Improve Cardiac Function Compared with Valsartan in Patients Suffering Nonvalvular Atrial Fibrillation without Systolic Heart Failure
This study investigates the effect of sacubitril/valsartan (Sac/Val) in patients diagnosed with nonvalvular atrial fibrillation (AF) without systolic heart failure (SHF).Nonvalvular AF patients without SHF admitted to the People's Hospital of Bortala Mongol Autonomous Prefecture from December 2020 to December 2021 were enrolled and randomly divided into Sac/Val treatment group (group T) and valsartan treatment group (group C, control). For subgroup analysis, patients were divided into subgroups with and without diastolic heart failure (DHF). After 1-month adaptive phase and subsequent 3-month treatment period, patients wer...
Source: International Heart Journal - November 29, 2023 Category: Cardiology Authors: Mingxin Zhu Jianfeng Guo Badeng Qiqike Xeri Nay Shan Dan Aidina Kuransi Gaokai Hu Zhangtong Han Dong Hou Ailifeilai Aili Bin Xia Ping Chen Bayin Bate Jiangjiao Xie Source Type: research
Adherence to Congestive Heart Failure Guidelines and Outcome in the Middle East
CONCLUSION: Despite of our full support to full CHFrEF guideline adherence, we recognize how hard this task to be achieved, nevertheless this study supports the theme that any guideline adherence is correlated with better morbidity and mortality rates over a long term follow up.PMID:38018202 | DOI:10.2174/011573403X256576231017110252 (Source: Current Cardiology Reviews)
Source: Current Cardiology Reviews - November 29, 2023 Category: Cardiology Authors: Raed Aqel Tareq Alzughayyar Jihad Zalloum Qais Salah Qutaiba Qafisheh Mahmoud Izraiq Source Type: research
Sacubitril/Valsartan Cannot Improve Cardiac Function Compared with Valsartan in Patients Suffering Nonvalvular Atrial Fibrillation without Systolic Heart Failure
This study investigates the effect of sacubitril/valsartan (Sac/Val) in patients diagnosed with nonvalvular atrial fibrillation (AF) without systolic heart failure (SHF).Nonvalvular AF patients without SHF admitted to the People's Hospital of Bortala Mongol Autonomous Prefecture from December 2020 to December 2021 were enrolled and randomly divided into Sac/Val treatment group (group T) and valsartan treatment group (group C, control). For subgroup analysis, patients were divided into subgroups with and without diastolic heart failure (DHF). After 1-month adaptive phase and subsequent 3-month treatment period, patients wer...
Source: International Heart Journal - November 29, 2023 Category: Cardiology Authors: Mingxin Zhu Jianfeng Guo Badeng Qiqike Xeri Nay Shan Dan Aidina Kuransi Gaokai Hu Zhangtong Han Dong Hou Ailifeilai Aili Bin Xia Ping Chen Bayin Bate Jiangjiao Xie Source Type: research
Adherence to Congestive Heart Failure Guidelines and Outcome in the Middle East
CONCLUSION: Despite of our full support to full CHFrEF guideline adherence, we recognize how hard this task to be achieved, nevertheless this study supports the theme that any guideline adherence is correlated with better morbidity and mortality rates over a long term follow up.PMID:38018202 | DOI:10.2174/011573403X256576231017110252 (Source: Current Cardiology Reviews)
Source: Current Cardiology Reviews - November 29, 2023 Category: Cardiology Authors: Raed Aqel Tareq Alzughayyar Jihad Zalloum Qais Salah Qutaiba Qafisheh Mahmoud Izraiq Source Type: research
Sacubitril/Valsartan Cannot Improve Cardiac Function Compared with Valsartan in Patients Suffering Nonvalvular Atrial Fibrillation without Systolic Heart Failure
This study investigates the effect of sacubitril/valsartan (Sac/Val) in patients diagnosed with nonvalvular atrial fibrillation (AF) without systolic heart failure (SHF).Nonvalvular AF patients without SHF admitted to the People's Hospital of Bortala Mongol Autonomous Prefecture from December 2020 to December 2021 were enrolled and randomly divided into Sac/Val treatment group (group T) and valsartan treatment group (group C, control). For subgroup analysis, patients were divided into subgroups with and without diastolic heart failure (DHF). After 1-month adaptive phase and subsequent 3-month treatment period, patients wer...
Source: International Heart Journal - November 29, 2023 Category: Cardiology Authors: Mingxin Zhu Jianfeng Guo Badeng Qiqike Xeri Nay Shan Dan Aidina Kuransi Gaokai Hu Zhangtong Han Dong Hou Ailifeilai Aili Bin Xia Ping Chen Bayin Bate Jiangjiao Xie Source Type: research
Adherence to Congestive Heart Failure Guidelines and Outcome in the Middle East
CONCLUSION: Despite of our full support to full CHFrEF guideline adherence, we recognize how hard this task to be achieved, nevertheless this study supports the theme that any guideline adherence is correlated with better morbidity and mortality rates over a long term follow up.PMID:38018202 | DOI:10.2174/011573403X256576231017110252 (Source: Current Cardiology Reviews)
Source: Current Cardiology Reviews - November 29, 2023 Category: Cardiology Authors: Raed Aqel Tareq Alzughayyar Jihad Zalloum Qais Salah Qutaiba Qafisheh Mahmoud Izraiq Source Type: research
Sacubitril/Valsartan Cannot Improve Cardiac Function Compared with Valsartan in Patients Suffering Nonvalvular Atrial Fibrillation without Systolic Heart Failure
This study investigates the effect of sacubitril/valsartan (Sac/Val) in patients diagnosed with nonvalvular atrial fibrillation (AF) without systolic heart failure (SHF).Nonvalvular AF patients without SHF admitted to the People's Hospital of Bortala Mongol Autonomous Prefecture from December 2020 to December 2021 were enrolled and randomly divided into Sac/Val treatment group (group T) and valsartan treatment group (group C, control). For subgroup analysis, patients were divided into subgroups with and without diastolic heart failure (DHF). After 1-month adaptive phase and subsequent 3-month treatment period, patients wer...
Source: International Heart Journal - November 29, 2023 Category: Cardiology Authors: Mingxin Zhu Jianfeng Guo Badeng Qiqike Xeri Nay Shan Dan Aidina Kuransi Gaokai Hu Zhangtong Han Dong Hou Ailifeilai Aili Bin Xia Ping Chen Bayin Bate Jiangjiao Xie Source Type: research
Adherence to Congestive Heart Failure Guidelines and Outcome in the Middle East
CONCLUSION: Despite of our full support to full CHFrEF guideline adherence, we recognize how hard this task to be achieved, nevertheless this study supports the theme that any guideline adherence is correlated with better morbidity and mortality rates over a long term follow up.PMID:38018202 | DOI:10.2174/011573403X256576231017110252 (Source: Current Cardiology Reviews)
Source: Current Cardiology Reviews - November 29, 2023 Category: Cardiology Authors: Raed Aqel Tareq Alzughayyar Jihad Zalloum Qais Salah Qutaiba Qafisheh Mahmoud Izraiq Source Type: research
Sacubitril/Valsartan Cannot Improve Cardiac Function Compared with Valsartan in Patients Suffering Nonvalvular Atrial Fibrillation without Systolic Heart Failure
This study investigates the effect of sacubitril/valsartan (Sac/Val) in patients diagnosed with nonvalvular atrial fibrillation (AF) without systolic heart failure (SHF).Nonvalvular AF patients without SHF admitted to the People's Hospital of Bortala Mongol Autonomous Prefecture from December 2020 to December 2021 were enrolled and randomly divided into Sac/Val treatment group (group T) and valsartan treatment group (group C, control). For subgroup analysis, patients were divided into subgroups with and without diastolic heart failure (DHF). After 1-month adaptive phase and subsequent 3-month treatment period, patients wer...
Source: International Heart Journal - November 29, 2023 Category: Cardiology Authors: Mingxin Zhu Jianfeng Guo Badeng Qiqike Xeri Nay Shan Dan Aidina Kuransi Gaokai Hu Zhangtong Han Dong Hou Ailifeilai Aili Bin Xia Ping Chen Bayin Bate Jiangjiao Xie Source Type: research
Adherence to Congestive Heart Failure Guidelines and Outcome in the Middle East
CONCLUSION: Despite of our full support to full CHFrEF guideline adherence, we recognize how hard this task to be achieved, nevertheless this study supports the theme that any guideline adherence is correlated with better morbidity and mortality rates over a long term follow up.PMID:38018202 | DOI:10.2174/011573403X256576231017110252 (Source: Current Cardiology Reviews)
Source: Current Cardiology Reviews - November 29, 2023 Category: Cardiology Authors: Raed Aqel Tareq Alzughayyar Jihad Zalloum Qais Salah Qutaiba Qafisheh Mahmoud Izraiq Source Type: research
Sacubitril/Valsartan Cannot Improve Cardiac Function Compared with Valsartan in Patients Suffering Nonvalvular Atrial Fibrillation without Systolic Heart Failure
This study investigates the effect of sacubitril/valsartan (Sac/Val) in patients diagnosed with nonvalvular atrial fibrillation (AF) without systolic heart failure (SHF).Nonvalvular AF patients without SHF admitted to the People's Hospital of Bortala Mongol Autonomous Prefecture from December 2020 to December 2021 were enrolled and randomly divided into Sac/Val treatment group (group T) and valsartan treatment group (group C, control). For subgroup analysis, patients were divided into subgroups with and without diastolic heart failure (DHF). After 1-month adaptive phase and subsequent 3-month treatment period, patients wer...
Source: International Heart Journal - November 29, 2023 Category: Cardiology Authors: Mingxin Zhu Jianfeng Guo Badeng Qiqike Xeri Nay Shan Dan Aidina Kuransi Gaokai Hu Zhangtong Han Dong Hou Ailifeilai Aili Bin Xia Ping Chen Bayin Bate Jiangjiao Xie Source Type: research
Adherence to Congestive Heart Failure Guidelines and Outcome in the Middle East
CONCLUSION: Despite of our full support to full CHFrEF guideline adherence, we recognize how hard this task to be achieved, nevertheless this study supports the theme that any guideline adherence is correlated with better morbidity and mortality rates over a long term follow up.PMID:38018202 | DOI:10.2174/011573403X256576231017110252 (Source: Current Cardiology Reviews)
Source: Current Cardiology Reviews - November 29, 2023 Category: Cardiology Authors: Raed Aqel Tareq Alzughayyar Jihad Zalloum Qais Salah Qutaiba Qafisheh Mahmoud Izraiq Source Type: research
Sacubitril/Valsartan Cannot Improve Cardiac Function Compared with Valsartan in Patients Suffering Nonvalvular Atrial Fibrillation without Systolic Heart Failure
This study investigates the effect of sacubitril/valsartan (Sac/Val) in patients diagnosed with nonvalvular atrial fibrillation (AF) without systolic heart failure (SHF).Nonvalvular AF patients without SHF admitted to the People's Hospital of Bortala Mongol Autonomous Prefecture from December 2020 to December 2021 were enrolled and randomly divided into Sac/Val treatment group (group T) and valsartan treatment group (group C, control). For subgroup analysis, patients were divided into subgroups with and without diastolic heart failure (DHF). After 1-month adaptive phase and subsequent 3-month treatment period, patients wer...
Source: International Heart Journal - November 29, 2023 Category: Cardiology Authors: Mingxin Zhu Jianfeng Guo Badeng Qiqike Xeri Nay Shan Dan Aidina Kuransi Gaokai Hu Zhangtong Han Dong Hou Ailifeilai Aili Bin Xia Ping Chen Bayin Bate Jiangjiao Xie Source Type: research
